Non-latex Ultrasound Probe Covers Market Size, Share, and Industry Analysis, By Sterility (Sterile and Non-sterile), By Material (Polyethylene, Polyurethane, Polyisoprene, and Others), By Diagnosis Type (Endocavity Examination, Superficial Examination, and Intraoperative Procedures), By End-user (Hospitals & ASCs, Diagnostics Centers, and Others), and Regional Forecast, 2024-2032

An ultrasound probe cover is a physical barrier that is designed to prevent cross-contamination during an ultrasound examination. These covers are available in both latex and non-latex materials.

Non-latex ultrasound probe covers are made from various polymers, including polyethylene, polyurethane, and polyisoprene. These latex-free covers are intended for diagnostic and scanning examinations, especially when a patient is suspected of having a latex allergy. While these polymer-based covers are a good alternative to latex covers, they also tend to be more expensive.

Latex-free ultrasound probe covers are used for various types of ultrasound examinations, including endocavity examinations (endorectal and endovaginal imaging), general-purpose examinations, and intraoperative procedures. Additionally, these covers are necessary for a wide range of interventional procedures, such as vascular access procedures (catheter or IV placements), radiology (organ biopsies and injections), and anesthesiology (nerve block procedures).

Furthermore, the increasing geriatric population, along with the rising incidences of traumatic injuries, cancers, cardiovascular diseases, and other chronic diseases, has led to a significant increase in the number of intraoperative procedures. Thus, an increasing number of intraoperative procedures generates the demand for ultrasound probes and covers, which are necessary during and after surgeries. These are some of the factors driving the market growth.

The COVID-19 pandemic positively impacted the non-latex ultrasound probe covers market in 2020. The market experienced an increased demand for ultrasound probe disinfection during the pandemic. This is due to the increased demand for medical supplies such as ultrasound probe covers. Additionally, due to the widespread prevalence of COVID-19 globally, the number of ultrasound examinations requested for both COVID-19-positive and suspected patients significantly increased. Healthcare providers deployed the potential of ultrasound diagnosis in these cases, mainly for the point-of-care applications for the triage, monitoring, and diagnosis of COVID-19 patients.

• For example, as per an article provided by BioMed Central Ltd in December 2020, lung ultrasound (LUS) had shown a superior sensitivity compared to X-ray in patients with acute respiratory failure, and LUS was a more feasible and practical alternative. Thus, most lung examinations were carried out with the help of ultrasound probes.

Therefore, the market growth was greatly enhanced by an increase in the adoption of ultrasound probes and non-latex ultrasound probe covers during the pandemic.

Segmentation

Key Insights

The following key insights are covered in the report:

• Pricing Analysis, Non-latex Ultrasound Probe Covers, By Key Countries


• Prevalence of Key Diseases, By Key Countries, 2023


• Key Industry Developments


• Impact of COVID-19 on the Market

Analysis by Diagnosis Type

Based on the diagnosis type, the market can be segmented into endocavity examination, superficial examination, and intraoperative procedures.

The endocavity examination segment is anticipated to hold a significant market share throughout the forecast period. The growth of the segment is mainly attributed to the growing prevalence of bladder and prostate cancers, as these medical conditions use ultrasound probes for endocavity examinations. Hence, the growing use of ultrasound probes ultimately increases the use of non-latex ultrasound probe covers for endocavity examinations.

• For instance, as per the data provided by the World Health Organization in February 2024, in 2022, around 1.5 million prostate cancer cases were diagnosed across the world. Therefore, market growth is expected to be driven by the increasing use of ultrasound probes and non-latex probe covers for prostate cancer diagnosis.

Furthermore, the intraoperative procedures segment held a considerable market share in 2023, mainly due to the increasing usage of ultrasound probes during intraoperative procedures due to their real-time imaging capabilities.

Regional Analysis

To gain extensive insights into the market, Request for Customization

Based on region, the non-latex ultrasound probe covers market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for a significant market share in 2023 and is expected to exhibit significant CAGR throughout the forecast period. Also, the growing use of ultrasound technology as medical imaging due to its non-invasiveness and ability to produce real-time images leads to the increasing demand for ultrasound probes and covers in the U.S. market.

Moreover, the presence of established players in the market, such as CIVCO Medical Solutions, Sheathing Technologies, Inc., EDM Medical Solutions, and others involved in providing non-latex ultrasound probe covers for diagnostic purposes, which is one of the factors contributing to market growth in the region.

Furthermore, the Asia Pacific region is expected to grow at a significant CAGR during the forecast period. The regional growth is primarily attributed to the increase in the geriatric population and the rapid surge in the number of ultrasound diagnostic procedures for the diagnosis of several types of disorders.

Key Players Covered

The report includes the profiles of key players, such as GE HealthCare, Cone Instruments, Sheathing Technologies, Inc., CIVCO Medical Solutions, and IMA-X s.a.

Key Industry Developments

• In December 2021, GE Healthcare announced the acquisition of BK Medical to expand its ultrasound business from diagnostics to surgical and therapeutic interventions.


• In January 2019, AMP Ltd announced that it had started supplying patented U.S. FDA-approved and CE marked Viral barrier adhesive and contoured probe covers in the European market.


• In March 2016, Sheathing Technologies, Inc. announced that the U.S. FDA had approved the coverage of its viral barrier ultrasound probe.